A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

Bryostatin 1 is a macrocyclic lactone derived from the marine invertebrate Bugula neritina. In vitro, bryostatin 1 activates protein kinase C (PKC), induces the differentiation of a number of cancer cell lineages, exhibits anti-tumour activity and augments the response of haemopoietic cells to certa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayson, G. C., Crowther, D., Prendiville, J., McGown, A. T., Scheid, C., Stern, P., Young, R., Brenchley, P., Chang, J., Owens, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033979/
https://www.ncbi.nlm.nih.gov/pubmed/7640233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033979/
https://www.ncbi.nlm.nih.gov/pubmed/7640233

Ejemplares similares